Cancer Patients’ Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life
Open Access
- 1 February 2021
- journal article
- research article
- Published by Taylor & Francis Ltd in Patient Preference and Adherence
- Vol. ume 15, 453-465
- https://doi.org/10.2147/ppa.s292462
Abstract
Purpose: To evaluate which side effects of chemotherapy are considered most burdensome by patients with cancer, identify which health care professionals pay most attention to symptoms associated with chemotherapy-induced myelosuppression (CIM) from the patient perspective, and capture the “patient voice” describing how CIM impacts their daily lives. Participants and Methods: Online survey of participants with breast, lung, or colorectal cancer who had received chemotherapy within the past 12 months and experienced ≥ 1 episode of CIM in the past year. Participants were asked to answer close-ended questions and provide qualitative responses to: “In your own words, please describe how side effects from myelosuppression have impacted your life.” Results: Among 301 survey participants, fatigue was the most frequently reported side effect of chemotherapy; 55% of participants rated fatigue as highly bothersome (9 or 10 on a 1– 10 scale of “bothersomeness”). Participants rated symptoms associated with CIM, including fatigue, weakened immune system (infections), bleeding and/or bruising, and shortness of breath, as being as bothersome as other side effects of chemotherapy, including alopecia, neuropathy, and nausea/vomiting. Overall, 24– 43% of participants thought that CIM and its symptoms had a negative impact on their daily lives, including their ability to complete tasks at home and work, and to socialize. Qualitative responses supported these findings; participants highlighted that CIM-related symptoms, particularly fatigue and fear of infections, affected their ability to be physically active, complete work, or continue meaningful relationships with friends and family. Conclusion: Participants described a real-world impact of CIM that often isolates them from family and friends, and means that they are unable to work or perform tasks of daily living. Using measures that help patients to recognize and communicate the signs and symptoms of CIM might increase the likelihood of maintaining daily lives as close to normal as possible, during and after chemotherapy treatment.Keywords
This publication has 40 references indexed in Scilit:
- Unmet Information Needs and Quality of Life in Young Breast Cancer Survivors in JapanCancer Nursing, 2015
- Antineoplastic Agents and the Associated Myelosuppressive EffectsJournal of Pharmacy Practice, 2014
- Role of nurses in the assessment and management of chemotherapy-related side effects in cancer patientsNursing: Research and Reviews, 2014
- The Nurse’s Role in Managing Chemotherapy-Induced Nausea and VomitingCancer Nursing, 2014
- Transfusions and patient burden in chemotherapy-induced anaemia in FranceTherapeutic Advances in Medical Oncology, 2014
- Platelet transfusions: trigger, dose, benefits, and risksF1000 Medicine Reports, 2010
- Understanding the Role of Physician Assistants in OncologyJournal of Oncology Practice, 2010
- Fatigue in cancer: A review of literatureIndian Journal of Palliative Care, 2009
- The social and emotional toll of chemotherapy ? patients' perspectivesEuropean Journal of Cancer Care, 2007
- Changing patient perceptions of the side effects of cancer chemotherapyCancer, 2002